Results
89
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
89 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.80 | 0.1% | 107.3% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.40 | -6.0% | 6.4% | SEK 379.6m | SEK 2.20 | PS4.1x | E90.4% | n/a | Tech | ||
YUBICO | SEK 235.00 | -12.6% | 134.5% | SEK 20.2b | SEK 267.50 | PE122.2x | E43.8% | n/a | Software | ||
CTT | SEK 273.00 | -0.7% | 26.4% | SEK 3.4b | n/a | PE33.6x | E24.8% | 2.0% | Capital Goods | ||
YIELD | SEK 2.32 | -2.1% | -67.3% | SEK 132.9m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
MAGLE | SEK 40.40 | -3.8% | 16.8% | SEK 436.3m | SEK 50.00 | PE56.7x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
EDYOU | SEK 1.22 | -10.0% | 9.4% | SEK 49.4m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOA B | SEK 157.00 | 3.0% | -49.8% | SEK 13.9b | SEK 326.40 | PS55x | E104.2% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.65 | -10.5% | -71.1% | SEK 222.7m | SEK 7.90 | PS30.5x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.26 | -4.2% | -27.6% | SEK 244.4m | SEK 3.65 | PS2.5x | E104.9% | n/a | Tech | ||
CRAD B | SEK 41.45 | -4.6% | 42.9% | SEK 1.4b | SEK 57.00 | PE26.1x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.04 | -8.7% | -32.3% | SEK 298.3m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
FLEXQ | SEK 10.40 | -5.5% | -61.5% | SEK 139.4m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
CTM | SEK 6.09 | -13.6% | -74.1% | SEK 460.7m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
KLAR | SEK 0.36 | 13.3% | -42.1% | SEK 46.5m | SEK 1.00 | PB1.6x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.24 | -11.4% | -48.3% | SEK 260.0m | SEK 2.80 | PS4x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 6.75 | -4.9% | -32.2% | SEK 199.2m | SEK 16.50 | PS3.8x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 21.10 | 5.5% | -18.8% | SEK 741.3m | SEK 22.00 | PS2.5x | E108.0% | n/a | Software | ||
TRUE B | SEK 32.30 | -4.7% | -15.0% | SEK 11.2b | SEK 54.83 | PE23.4x | E21.5% | 1.2% | Software | ||
EQT | SEK 305.10 | -10.5% | 28.1% | SEK 360.8b | SEK 360.17 | PE104x | E56.9% | 1.2% | Diversified Financials | ||
FNOX | SEK 61.76 | -7.2% | 0.4% | SEK 37.7b | SEK 73.00 | PE58x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.64 | -6.3% | 28.2% | SEK 1.7b | SEK 13.30 | PS26.2x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
NIUTEC | SEK 5.80 | -12.1% | -47.2% | SEK 121.4m | SEK 9.50 | PB1.4x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods |